Extracellular Keratins: An Update

  • Robert D. Cardiff
  • Shoichiro Taniuchi
  • Daer He


Four years ago we announced the production of a series of monoclonal antibodies which react with the major epithelial keratins of MCF7 and other breast cancer cell lines (1). One of the antibodies, UCD/PR 10.11, has proven to be an excellent reagent, when used in the immunoperoxidase technique, for the diagnosis of epithelial malignancies (2). UCD/PR 10.11 reacts with CK 8 and 18. It has a superb signal-to-noise ratio in staining almost all simple epithelia and is thought by some to be one of the best diagnostic monoclonal anti-keratin available for immunopathology (3). It is now commercially available through Triton Biosciences, Inc.


Breast Cancer Bladder Cancer MCF7 Cell Transitional Cell Carcinoma Benign Breast Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    R. Chan, P.V. Rossitto, B.F. Edwards and R.D. Cardiff. Intracellular and extracellular keratins of human mammary epithelial cells. In: “Monoclonal Antibodies and Breast Cancer,” R.L. Ceriani, ed., M. Nijhoff Publishing. Dordrecht and Lancaster, Boston, (1985).Google Scholar
  2. 2.
    R. Chan, B.F. Edwards, R. Hu, P.V. Rossitto, B.H. Min, J.K. Lund, and R.D. Cardiff. Characterization of two monoclonal antibodies in an immunohistochemical study of keratin 8 and 18 expression. Am. J. Clin. Path. 89:472–480 (1988).PubMedGoogle Scholar
  3. 3.
    H. Battifora, Diagnostic uses of antibodies to keratins. A review and immunohistochemical comparison of seven monoclonal and three polyclonal antibodies. In: “Progress in Surgical Pathology,” Vol. VIII. C. Fenoglio, M. Wolff, eds., Field and Wood, Inc., Philadelphia, 1987.Google Scholar
  4. 4.
    A.B. Brabon, J.F. Williams and R.D. Cardiff. A monoclonal antibody to a human breast cancer protein released in response to estrogen. Cancer Res. 44:2704–2710 (1984).PubMedGoogle Scholar
  5. 5.
    R. Chan, P.V. Rossitto, B.F. Edwards and R.D. Cardiff. Presence of proteolytically processed keratins in the culture medium of MCF-7 cells. Cancer Res. 46:6353–6359, (1986).PubMedGoogle Scholar
  6. 6.
    P.E. Bowden, R.A. Quinlan, D. Breitkreutz, and N.E. Fusenig. Proteolytic modification of acid and basic keratins during terminal differentiation of mouse and human epidermis. Eur. J. Biochem. 142:29–36 (1984).PubMedCrossRefGoogle Scholar
  7. 7.
    P.V. Rossitto, R. Chan, M. Strand, C.H. Miller, Wm. C. Baker, A.D. Deitch, R. de Vere White and R.D. Cardiff. Characterization of urinary keratin number 18 using a new assay. J. Urol. 140:431–435 (1988).PubMedGoogle Scholar
  8. 8.
    B. Bjorklund, and V. Bjorklund. Specificity and basis of the tissue polypeptide antigen. Cancer Detect. Prev. 6: 41–50 (1983).PubMedGoogle Scholar
  9. 9.
    P.V. Rossitto, R. Chan, B.F. Edwards and R.D. Cardiff. A quantitative immunoradiometric assay that detects a soluble form of cytokeratin no. 18 in serum. 2nd International Workshop on Monoclonal Antibodies and Breast Cancer. November, 1986.Google Scholar
  10. 10.
    W. C. Baker, R. deVere White, P.V. Rossitto, B.H. Min and R.D. Cardiff. Quantitative analysis of keratin 18 in urine of patients with bladder cancer. J. Urol. 140:436–439 (1988).PubMedGoogle Scholar
  11. 11.
    B.F. Edwards, P.V. Rossitto, W.C. Baker, R.D. Cardiff, M. Strand, A.D. Deitch and R. deVere White. Transitional cell cytokeratins as a second parameter in flow cytometry of bladder cancer. World J. Urol. 5:123–126 (1987).CrossRefGoogle Scholar
  12. 12.
    L.A. Diaz, S.A.P. Sampaio, C.R. Martins, An autoantibody in pemphigus serum, specific for the 59KD keratin, selectively binds the surface of keratinocytes: Evidence for an extracellular keratin domain. J. Invest. Dermatol. 89:287–295 (1987).PubMedCrossRefGoogle Scholar
  13. 13.
    S.J. DeNardo, G.L. DeNardo, L.F. O’Grady, J-S. Peng, D.J. Macey, S.L. Mills, R.D. Cardiff and A.L. Epstein. Human kinetic distribution of I123 F(Ab1)2 and FAB compared to the parent I123 intact antibody. Society of Nuclear Medicine 32nd Annual Meeting, June 2–5, 1985.Google Scholar
  14. 14.
    D. He, S. Taniuchi, C.H. Sun, M.W. Berns, P.J. Donald, and R.D. Cardiff. Monoclonal antibody-photosensitizer conjugates (MAPS:PS) versus surface epitopes attach to and photoinactivate tumor cells. Canadian and United States Academy of Pathology, Annual Meeting, San Francisco, CA. March 1989.Google Scholar
  15. 15.
    S.D. Georgatos, and G. Blobel. Two distinct attachment sites for vimentin along the plasma membrane and the nuclear envelope in avian erythrocytes: A basis for a vectorial assembly of intermediate filaments. J. Cell Biology 105:105–115 (1987).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Robert D. Cardiff
    • 1
  • Shoichiro Taniuchi
    • 1
  • Daer He
    • 1
  1. 1.Department of PathologyUniversity of California School of MedicineDavisUSA

Personalised recommendations